disclosures
play

Disclosures Management of the Chest Pain Astra Zeneca Advisory - PDF document

12/16/16 Management of the Chest Pain Management of the Chest Pain Patient in the ED in 2016 Patient in the ED in 2017 EA Amsterdam, MD EA Amsterdam, MD Distinguished Professor, Internal Medicine Distinguished Professor, Internal Medicine


  1. 12/16/16 Management of the Chest Pain Management of the Chest Pain Patient in the ED in 2016 Patient in the ED in 2017 EA Amsterdam, MD EA Amsterdam, MD Distinguished Professor, Internal Medicine Distinguished Professor, Internal Medicine Associate Chief (academic affairs) Cardiovascular Medicine Associate Chief (academic affairs) Cardiovascular Medicine Master Clinician Teacher Master Clinician Teacher UC Davis School of Medicine, Sacramento, CA UC Davis School of Medicine, Sacramento, CA Disclosures Management of the Chest Pain • Astra Zeneca – Advisory Board Patient in the ED in 2017 • Relypsa – Advisory Board EA Amsterdam, MD Distinguished Professor, Internal Medicine Associate Chief (academic affairs) Cardiovascular Medicine Master Clinician Teacher UC Davis School of Medicine, Sacramento, CA 1

  2. 12/16/16 Conflicts “The best in this kind are but shadows…” My only conflicts are inner conflicts Shakespeare, Midsummer Night’s Dream and I don’t care to share them! Approach to the Patient with Approach to the Patient with Chest Pain in the ED Chest Pain in the ED • Magnitude of the problem • Magnitude of the problem • Goal of evaluation • Goal of evaluation • Identification of low risk • Identification of low risk • “Confirmatory” tests • “Confirmatory” tests • CPU and accelerated diagnostic protocols • CPU and accelerated diagnostic protocols 2

  3. 12/16/16 Patient with chest pain in ED Low Risk Chest Pain Magnitude of the Problem • Magnitude of the problem • >7,000,000 ED visits/yr in US for chest pain • Goal of evaluation • Minority are for CVD • Low risk • Usually no specific diagnosis, no M & M • “Confirmatory” tests • Single largest group of patients • CPU and accelerated diagnostic protocols – Anxiety, panic, somatoform disorder Spectrum of Patients Presenting National Trend in Admissions for to ED with Acute Chest Pain Chest Pain Evaluation: 2006-2013 (>7,000,000/yr) STEMI <5% Reperfusion Non-STE ACS 20-30% ED chest pain evaluations: Antiischemic Rx 5,4 2006 5.4 million 2013 7.1 million Low Risk Chest Pain 65-75% Accelerated Dx Protocol (ADP) YEAR 3

  4. 12/16/16 Low Risk Chest Pain • Magnitude of the problem STEMI <5% • Goal of evaluation Reperfusion • Low Risk Non-STE ACS 20-30% • “Confirmatory” tests Antiischemic Rx • CPU and accelerated diagnostic protocols Low Risk Chest Pain 65-75% Accelerated Dx Protocol (ADP) Goal Goal Avert: • To exclude acute CVD event Inappropriate Discharges Missed ACS (2.3%, Pope, NEJM 2000) Medicolegal liability • Not to exclude CAD!!! Inappropriate Admissions • Confirm safety of discharge Inefficient resource utilization Major expense to system – For outpatient management 4

  5. 12/16/16 Spectrum of Patients Presenting to ED with Acute Chest Pain Low Risk Chest Pain (>7,000,000/yr) • Magnitude of the problem STEMI <5% • Goal of evaluation Reperfusion • Low risk Non-STE ACS 20-30% • “Confirmatory” tests Antiischemic Rx • CPU and accelerated diagnostic protocols Low Risk Chest Pain 65-75% Accelerated Dx Protocol (ADP) Acute CP Evaluation: Low Risk Low Risk Is Not No Risk <5% Probability of ACS – History – Typical or atypical CP “Confirmatory” test to – Exam – Clinically stable further reduce risk – ECG – Normal (or unchanged) – Troponin - Negative (x1-2) – Intermediate Risk - >65 yo, DM, CKD, CAD 5

  6. 12/16/16 Acute Chest Pain Evaluation • Goal of evaluation • Magnitude of the problem Multimarker • Low risk • “Confirmatory” tests BMIPP • CPU and accelerated diagnostic protocols “Confirmatory” Tests • Functional Neg. Predictive Value – Treadmill Ex–T >99% Scientific Statement of the American Heart Association – MPS (sestamibi, stress) >99% – Stress Echo ~95% • Anatomic – CTCA >99% – (MRI) 6

  7. 12/16/16 “Confirmatory” Tests Treadmill Exercise Testing in CPUs Adverse • Functional Neg. Predictive Value Neg PV Events No. Pts % Pos % Po Pos PV PV – Treadmill Ex–T >99% Ts Tsakonis 28 28 17. 17.8 100% 100% ---- ---- 0 – MPS (sestamibi, stress) >99% Ke Kerns et al 32 32 0 100% 100% ---- ---- 0 93 13.0 100% 46% Lew Lewis/ Am 0 Amsterdam – Stress Echo ~95% Gi Gibler et al 782 782 1. 1.2 99% 99% 44% 44% 0 Gibler et al Gi 100 100 7 100% 100% 0% 0% 0 • Anatomic Zalenski Za 224 224 8 98% 98% 16% 16% 0 – CTCA >99% Po Polanczyk 276 276 24 24 98% 98% 15% 15% 0 212 12.5 100% 57% 0 – (MRI) Kirk et al 13 98% 33% 0 Amsterdam et et al al 1000 30 d-1 yr Amsterdam et al, Circ 2010 Accelerated diagnostic protocol Treadmill Exercise Testing in CPUs (ADP) Adverse Neg PV Events No. Pts % Pos % Pos PV Po PV Ts Tsakonis 28 28 17.8 17. 100% 100% ---- ---- 0 • Serial ECGs Ke Kerns et al 32 32 0 100% 100% ---- ---- 0 93 13.0 100% 46% Lewis/ Am Lew 0 Amsterdam • Cardiac injury markers (Tn) Gi Gibler et al 782 782 1. 1.2 99% 99% 44% 44% 0 Gibler et al Gi 100 100 7 100% 100% 0% 0% 0 • (Confirmatory test) Zalenski Za 224 224 8 98% 98% 16% 16% 0 • LOS 2-12 hrs Po Polanczyk 276 276 24 24 98% 98% 15% 15% 0 212 12.5 100% 57% 0 Kirk et al 13 98% 33% 0 Amsterdam et et al al 1000 30 d-5yr Amsterdam et al, Circ 2010 7

  8. 12/16/16 Chest Pain Unit Acute Chest Pain Evaluation • Physical structure • “Virtual” Unit (UCDMC) • Goal of evaluation • Magnitude of the problem – Accelerated diagnostic protocol (ADP) • Low risk • Serial ECGs • “Confirmatory” tests • Cardiac injury markers • CPU and accelerated diagnostic protocols • LOS 2-12hrs Accelerated Diagnostic Protocol Accelerated Diagnostic Protocol ED CPU Clinically Stable Serial ECGs, Markers (1-2 sets) Negative ECG/Markers Low Risk To exclude ischemia/necrosis at rest CPU 8

  9. 12/16/16 Accelerated Diagnostic Protocol Accelerated Diagnostic Protocol CPU CPU Serial ECGs, Markers (1-2 sets) Serial ECGs, Markers (1-2 sets) if negative if negative “Confirmatory” test Confirmatory test To exclude inducible ischemia or anatomic CAD Accelerated Diagnostic Protocol UCDMC CPU • >20 years, >10,000 patients CPU – Elderly/young, M/F, +/- CAD, antianginal drugs, DM. CKD Serial ECGs, Markers (1-2 sets) – TIMI risk score not applied in CPU patients • ACC/AHA guidelines if negative – ETT Confirmatory test • If ECG WNL and patient can exercise • 1/3 of our patients require a different test • Negative Predictive Value 99.7% if negative if positive • (No confirmatory test?) Discharge Admit • At other ctrs - MPS, Stress Echo, CTA w/follow-up 9

  10. 12/16/16 Early ETT: Exercise-Induced Chest Pain? n = 318 2.0% Accelerated Dx Protocol in Low Evolving Concepts in CPU Evaluation Risk Women Presenting with CP • “Avoidable Utilization of the CPOU: Evaluation of • N = 212, <50 yo, no DM/smoking Very Low Risk Patients”, Mahler et al, CritPathCard 12:59;2013 • ED - Clinically stable, normal ECG and markers • “Chest Pain in the ED: The Case Against Our • ETT or stress imaging - 171, No Confirmatory Test = 41 Current Practice of Routine Noninvasive Testing”, • Neg CPU evaluation in all patients, all directly discharged Prasad et al, Arch Int Med 172:1306;2012 • 5 yr FU 2 fatalities (PPCM, pancreatitis) 2 hr ADP, No Predischarge Test • Conclusion: All CP patients do not • TIMI score 0, ECG neg, hs-Ti neg at 0 and 2 hr. require confirmatory testing • NPV >99.6% at 30 days. Than, Lancet, 2012 Eddin and Amsterdam, JACC, 2012 10

  11. 12/16/16 No Predischarge Test JAMAIntMed 2014 UC Davis In the current state of our knowledge, it is reasonable to call for a • If low risk criteria fulfilled halt to routine cardiac testing in favor of physician discretion in selection of patients for predischarge testing. – 40% pts discharged with no confirmatory test – LOS in CPU 2-12 hr – NPV >99.7% at 30 d. FU (1 event in 1138 pts) 11

  12. 12/16/16 CTA in the ED ROMICAT • 12 studies (2005-2012) ED ETT – 99.7% NPV • N = 5865 pts, 30-81 y.o. Discharge in <6 hr. • NPV 96-100% (ED and >1 yr) Cost $1200 (UCDMC) • PPV 13-87% 38% of patients did not qualify for CTCA • LOS 7-21 hrs • Radiation 5-18 mSv Schlett et al, JACCi 2011;4:461 CTA in ED – Exclusions Radiation CTA ETT CAD- h/o MI, PCI or CABG YES NO CKD YES NO COPD YES NO Allergy to contrast/ shellfish YES NO • 10-20 mSv exposure = 1 new Ca for BMI ≥39 kg/m 2 YES NO every 500-1000 scans Contraindication to β-blocker YES NO Inability to hold breath YES NO • US National Research Council on Pregnancy YES NO CT imaging within past 48 hours YES NO ionizing radiation (2005) Normal CTA/cor angiography in previous year YES NO Cocaine use within past 48 hours YES NO Radiographic abnormalities YES NO HR >90 bpm YES NO 12

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend